joint strategic needs assessment foundation profile - JSNA

Interative Hull Atlas: www.hullpublichealth.org/Pages/hull_atlas.htm More information: www.jsnaonline.org and www.hullpublichealth.org
10.2.5.5 Five Year Survival Rates .................................................................... 561
10.2.5.6 Inpatient Admissions in Relation to Deprivation .................................. 562
10.2.5.7 Mortality in Relation to Deprivation ..................................................... 563
10.2.5.8 Programme Budgeting ........................................................................ 563
10.3 Diabetes ....................................................................................................... 564
10.3.1 Risk Factors ............................................................................................. 564
10.3.2 Diagnosed and Modelled Prevalence ...................................................... 564
10.3.3 Inpatient Hospital Admissions .................................................................. 573
10.3.4 Mortality ................................................................................................... 574
10.3.5 Quality of Care ......................................................................................... 577
10.3.6 Health Equity Audit .................................................................................. 578
10.3.7 Diagnosed Prevalence in Relation to Deprivation .................................... 580
10.3.8 Inpatient Admissions in Relation to Deprivation ....................................... 582
10.3.9 Mortality in Relation to Deprivation .......................................................... 583
10.3.10 Prevalence, Inpatient Admissions and Mortality in Relation to Deprivation
................................................................................................................. 583
10.3.11 Progress Towards Targets ....................................................................... 585
10.3.12 Programme Budgeting and Outcomes ..................................................... 589
10.4 Chronic Kidney Disease ............................................................................. 591
10.4.1 Diagnosed and Modelled Prevalence ...................................................... 591
10.5 Respiratory Disease .................................................................................... 599
10.5.1 All Respiratory Disease ............................................................................ 599
10.5.1.1 Prevalence .......................................................................................... 599
10.5.1.2 Inpatient Hospital Admissions ............................................................. 601
10.5.1.3 Mortality .............................................................................................. 603
10.5.1.4 Progress Towards Targets ................................................................. 604
10.5.1.5 Programme Budgeting and Outcomes ............................................... 605
10.5.2 Asthma ..................................................................................................... 607
10.5.2.1 Diagnosed and Modelled Prevalence ................................................. 607
10.5.2.2 Programme Budgeting ........................................................................ 611
10.5.3 Chronic Obstructive Pulmonary Disease ................................................. 612
10.5.3.1 Definition............................................................................................. 612
10.5.3.2 Risk Factors ........................................................................................ 612
10.5.3.3 Diagnosed and Modelled Prevalence ................................................. 613
10.5.3.4 Inpatient Hospital Admissions ............................................................. 619
10.5.3.5 Mortality .............................................................................................. 621
10.5.3.6 Health Equity Audit ............................................................................. 625
10.5.3.7 Diagnosed Prevalence in Relation to Deprivation ............................... 625
10.5.3.8 Inpatient Admissions in Relation to Deprivation .................................. 627
10.5.3.9 Mortality in Relation to Deprivation ..................................................... 628
10.5.3.10 Mortality Within the Most Deprived National Quintile – Hull and
Comparators ....................................................................................... 629
10.5.3.11 Social Marketing ............................................................................. 631
10.5.3.12 Progress Towards Targets ............................................................. 631
10.5.3.13 Programme Budgeting .................................................................... 632
10.6 Epilepsy ....................................................................................................... 633
10.6.1 Diagnosed and Modelled Prevalence ...................................................... 633
Joint Strategic Needs Assessment Foundation Profile – Hull Health Profile: Release 3. March 2011. 11